Alzamend Neuro (ALZN) Return on Assets [ROA] (2021 - 2026)
Alzamend Neuro's Return on Assets [ROA] was -171.31% in fiscal Q1 2027 (quarter ended Jul 31, 2026), down 57.07 percentage points from -114.24% a year earlier but up 115.35 percentage points from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), Return on Assets [ROA] at Alzamend Neuro came in at -262.55%, down 90.05 percentage points from FY2025.
- Return on Assets [ROA] shows a five-year change of -47.00 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Assets [ROA] was -172.50% in FY2025 (+131.38 pp), -303.88% in FY2024 (-158.24 pp), -145.64% in FY2023 (-3.73 pp) and -141.90% in FY2022 (+73.66 pp).
- Quarterly Return on Assets [ROA] has moved between -1406.81% (fiscal Q4 2024) and -53.30% (fiscal Q2 2022) over five years.
- Compared with a year earlier, Return on Assets [ROA] has declined for three straight quarters, with an average year-over-year change of +447.29 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q3 2025 (a gain of 1312.26 percentage points); the worst was fiscal Q3 2024 (a drop of 1241.10 percentage points).
- Per Business Quant data, ALZN's Return on Assets [ROA] in the three fiscal quarters before Q1 2027 was -286.66% (Q4 2026), -154.20% (Q3 2026) and -103.03% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Alzamend Neuro | 6.61 Mn | 6.61 Mn | - | -171.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -171.31% |
| Apr 30, 2026 | -286.66% |
| Jan 31, 2026 | -154.20% |
| Oct 31, 2025 | -103.03% |
| Jul 31, 2025 | -114.24% |
| Apr 30, 2025 | -102.86% |
| Jan 31, 2025 | -92.06% |
| Oct 31, 2024 | -175.21% |
| Jul 31, 2024 | -642.59% |
| Apr 30, 2024 | -1,406.81% |
| Jan 31, 2024 | -1,404.32% |
| Oct 31, 2023 | -839.79% |
| Jul 31, 2023 | -359.77% |
| Apr 30, 2023 | -206.39% |
| Jan 31, 2023 | -163.22% |
| Oct 31, 2022 | -111.27% |
| Jul 31, 2022 | -97.90% |
| Apr 30, 2022 | -91.79% |
| Jan 31, 2022 | -72.39% |
| Oct 31, 2021 | -53.30% |
API Access
Alzamend Neuro Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();